Gaush Meditech Ltd

HK$4.45As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2407Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 4Y CAGR (45.24%)
Div yield —
ROE 4.22%
Medical Devices
Beta (5Y) (0.01)
PE TTM 7.324
TSR TTM (51.42%)
Mkt cap HK$629.4M
ROIC 4.21%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.89
10.03%
(22.20%)
Hold 2|9|6|11|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.04
0.04
0.05
4.49%
(2.85%)
11.88%
24.02%
Revenue¥M
34.54
34.89
36.16
38.00
0.88%
2.14%
7.63%
7.37%
Peers (US$80.28M)
Cap (US$)
PE
58.52M
4.683x
36.31M
—
34.98M
13.76x
Capital
TTM
5Y
10Y
Leveragex
3.375
0.228
0.174
EBIT/Intx
0.559
0.083
0.079
Own earn%
38.99
56.25
37.24
Sh yield%
24.75
19.60
19.30
Owners
Insiders/Inst%
13.49
89.78
Short interest%
5.09
SBC / revenue%
4.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
25–32
$1 testx
—
Incr. ROIC%
5